scispace - formally typeset
Search or ask a question
Institution

Halmstad University

EducationHalmstad, Sweden
About: Halmstad University is a education organization based out in Halmstad, Sweden. It is known for research contribution in the topics: Health care & Population. The organization has 924 authors who have published 2803 publications receiving 63392 citations.


Papers
More filters
Journal ArticleDOI
15 Apr 2014-Energy
TL;DR: In this article, the concept of 4th Generation District Heating (4GDH) was defined, including the relations to district cooling and the concepts of smart energy and smart thermal grids.

1,654 citations

Journal ArticleDOI
TL;DR: Some of the VANET research challenges that still need to be addressed to enable the ubiquitous deployment and widespead adoption of scalable, reliable, robust, and secure VANet architectures, protocols, technologies, and services are outlined.
Abstract: Recent advances in hardware, software, and communication technologies are enabling the design and implementation of a whole range of different types of networks that are being deployed in various environments. One such network that has received a lot of interest in the last couple of years is the Vehicular Ad-Hoc Network (VANET). VANET has become an active area of research, standardization, and development because it has tremendous potential to improve vehicle and road safety, traffic efficiency, and convenience as well as comfort to both drivers and passengers. Recent research efforts have placed a strong emphasis on novel VANET design architectures and implementations. A lot of VANET research work have focused on specific areas including routing, broadcasting, Quality of Service (QoS), and security. We survey some of the recent research results in these areas. We present a review of wireless access standards for VANETs, and describe some of the recent VANET trials and deployments in the US, Japan, and the European Union. In addition, we also briefly present some of the simulators currently available to VANET researchers for VANET simulations and we assess their benefits and limitations. Finally, we outline some of the VANET research challenges that still need to be addressed to enable the ubiquitous deployment and widespead adoption of scalable, reliable, robust, and secure VANET architectures, protocols, technologies, and services.

1,132 citations

Journal ArticleDOI
TL;DR: These recommendations provide stakeholders with an updated consensus on the pharmacological treatment of PsA and strategies to reach optimal outcomes in PsA, based on a combination of evidence and expert opinion.
Abstract: Background Since the publication of the European League Against Rheumatism recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence and new therapeutic agents have emerged. The objective was to update these recommendations. Methods A systematic literature review was performed regarding pharmacological treatment in PsA. Subsequently, recommendations were formulated based on the evidence and the expert opinion of the 34 Task Force members. Levels of evidence and strengths of recommendations were allocated. Results The updated recommendations comprise 5 overarching principles and 10 recommendations, covering pharmacological therapies for PsA from non-steroidal anti-inflammatory drugs (NSAIDs), to conventional synthetic (csDMARD) and biological (bDMARD) disease-modifying antirheumatic drugs, whatever their mode of action, taking articular and extra-articular manifestations of PsA into account, but focusing on musculoskeletal involvement. The overarching principles address the need for shared decision-making and treatment objectives. The recommendations address csDMARDs as an initial therapy after failure of NSAIDs and local therapy for active disease, followed, if necessary, by a bDMARD or a targeted synthetic DMARD (tsDMARD). The first bDMARD would usually be a tumour necrosis factor (TNF) inhibitor. bDMARDs targeting interleukin (IL)12/23 (ustekinumab) or IL-17 pathways (secukinumab) may be used in patients for whom TNF inhibitors are inappropriate and a tsDMARD such as a phosphodiesterase 4-inhibitor (apremilast) if bDMARDs are inappropriate. If the first bDMARD strategy fails, any other bDMARD or tsDMARD may be used. Conclusions These recommendations provide stakeholders with an updated consensus on the pharmacological treatment of PsA and strategies to reach optimal outcomes in PsA, based on a combination of evidence and expert opinion.

802 citations

Journal ArticleDOI
TL;DR: In this article, six different strategies have been proposed for the European Union (EU) energy system in the European Commission's report, Energy Roadmap 2050, the objective for these strategies is to ide...

672 citations

Journal ArticleDOI
TL;DR: The constant comparative method of grounded theory was first proposed by Glaser and Strauss as discussed by the authors, who were at the forefront of what can be called a "qua-qua...
Abstract: Approximately 40 years ago, Barney Glaser and Anselm Strauss and their joint research approach, the constant comparative method of grounded theory, were at the forefront of what can be called a qua...

578 citations


Authors

Showing all 939 results

NameH-indexPapersCitations
P. Johansson10058435961
Lars Samuelson9685036931
Nikos Ntoumanis7428219459
Björn Nilsson6023218580
Lars Hansson6032712065
Bengt Fridlund5742512222
Göran Svensson473487753
Lars Bengtsson473728621
Chris D. Nugent446019905
Sarah Pink4421311017
Jonas Larsson401227228
Michael Bordag392137168
Alexey Vinel392064787
Josef Bigun382026676
Magnus Lindwall371013498
Network Information
Related Institutions (5)
Linköping University
50K papers, 1.5M citations

90% related

Aalborg University
45.6K papers, 1.2M citations

89% related

Norwegian University of Science and Technology
68.9K papers, 1.9M citations

88% related

University of Southern Denmark
37.9K papers, 1.2M citations

86% related

RMIT University
82.9K papers, 1.7M citations

86% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20235
202230
2021210
2020217
2019190
2018230